News Center

News Center

June 03, 2016

ACT Oncology Is Now Precision Oncology

Flemington, NJ, June 3, 2016 – ACT Oncology, the leading contract research organization (CRO) specializing exclusively in the field of oncology, has changed its name to Precision Oncology (precisionforoncology.com). The new name reflects the significant expansion and integration of capabilities since joining Precision for Medicine earlier this year.

Precision Oncology combines unrivaled trial expertise with advanced biomarker solutions to accelerate the pathway to proof-of-concept for oncology innovators.

March 27, 2017 - March 30, 2017

AMCP 2017 Denver

AMCP is coming to Denver March 27th -30th, and Precision is looking forward to the chance to show off our capabilities and experts with a booth presence, three presentations, four posters and more! Look for us on the exhibitor floor in Booth 312, and check below for complete information on all of our scientific presentations:… Read more »

June 03, 2016

ACT Oncology Is Now Precision Oncology

Flemington, NJ, June 3, 2016 – ACT Oncology, the leading contract research organization (CRO) specializing exclusively in the field of oncology, has changed its name to Precision Oncology (precisionforoncology.com). The new name reflects the significant expansion and integration of capabilities since joining Precision for Medicine earlier this year.

Precision Oncology combines unrivaled trial expertise with advanced biomarker solutions to accelerate the pathway to proof-of-concept for oncology innovators.

March 21, 2017

A Conversation With Dan Renick in Pharmaceutical Commerce

Precision for Value president Dan Renick is interviewed for Pharmaceutical Commerce, providing his in-depth perspective on today’s payer and provider markets. Click here for the complete article.

June 03, 2016

ACT Oncology Is Now Precision Oncology

Flemington, NJ, June 3, 2016 – ACT Oncology, the leading contract research organization (CRO) specializing exclusively in the field of oncology, has changed its name to Precision Oncology (precisionforoncology.com). The new name reflects the significant expansion and integration of capabilities since joining Precision for Medicine earlier this year.

Precision Oncology combines unrivaled trial expertise with advanced biomarker solutions to accelerate the pathway to proof-of-concept for oncology innovators.

March 16, 2017

Commentary: Precision’s Jeremy Schafer on the Role of Payers in Antibiotic Stewardship

In a new commentary for Journal of Clinical Pathways, Precision for Value’s Jeremy Schafer outlines the role that payers can play in facilitating transitions of care while practicing antimicrobial stewardship. Click here to read the complete article.